pharma Moderna and Merck's Personalized Cancer Vaccine Clears Its First Phase 3 Test Aug 22, 2026, 9:05 PM
pharma Third Time's the Charm: Replimune Wins FDA Nod for Melanoma Drug After Two Rejections Aug 8, 2026, 3:38 PM